Tailoring antithrombotic strategies for high-risk AF populations

被引：0
|
作者：
Fernandez-Ruiz, Irene
机构：
[1] Nature Reviews Cardiology,
来源：
NATURE REVIEWS CARDIOLOGY | 2019年 / 16卷 / 06期
关键词：
D O I：
10.1038/s41569-019-0195-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A regimen that includes a P2Y12 inhibitor plus apixaban without aspirin results in less bleeding and hospitalizations, without significant differences in ischaemic events, than use of regimens that include a vitamin K antagonist, aspirin or both
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [21] Brca testing in high-risk populations
    Manchanda, Ranjit
    CLINICAL CANCER RESEARCH, 2015, 21
  • [22] Intervening in high-risk or vulnerable populations?
    Semenza, Jan C.
    Suk, Jonathan
    Manissero, Davide
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 98 (08) : 1351 - 1352
  • [23] Detection of COPD in high-risk populations
    Gourgoulianis, KI
    Hristou, K
    Molyvdas, PA
    CHEST, 2002, 121 (05) : 1721 - 1721
  • [24] STUDIES OF POPULATIONS AT HIGH-RISK FOR ALCOHOLISM
    SCHUCKIT, MA
    PSYCHIATRIC DEVELOPMENTS, 1985, 3 (01) : 31 - 63
  • [25] STUDIES OF POPULATIONS AT HIGH-RISK FOR ALCOHOLISM
    SCHUCKIT, MA
    ALCOHOL AND ALCOHOLISM, 1986, 21 (02): : A4 - A4
  • [26] PRIMARY PREVENTION AND HIGH-RISK POPULATIONS
    DANDREA, M
    PERSONNEL AND GUIDANCE JOURNAL, 1984, 62 (09): : 554 - 558
  • [27] Infection in high-risk populations - Preface
    Khardori, Nancy
    Khardori, Romesh
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2007, 21 (03) : XIII - XIV
  • [28] ESOPHAGEAL CANCER IN HIGH-RISK POPULATIONS
    RAAFAT, F
    LANCET, 1982, 1 (8280): : 1077 - 1077
  • [29] Comparison of effectiveness and cost of different HCV testing strategies in high-risk populations in China
    Chen, Bing
    Xu, Bing
    Cui, Hai-yan
    Ma, Zhong-hui
    Guo, Wen-hui
    Pei, Li-jian
    Xing, Wen-ge
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (02)
  • [30] Cardiovascular risk reduction in high-risk pediatric populations
    不详
    PEDIATRICS, 2007, 119 (03) : 618 - 621
12345